TY  - JOUR
TT  - The Effects of Curcuma Longa and Silybum Marianum on Carbon Tetrachloride Induced Chronic Hepatic Damage in Rats
AU  - Atasever, Ayhan
AU  - Baran, Oktay
AU  - Ekebaş, Görkem
PY  - 2017
DA  - December
JF  - Sağlık Bilimleri Dergisi
PB  - Erciyes Üniversitesi
WT  - DergiPark
SN  - 1018-3655
SP  - 240
EP  - 248
VL  - 26
IS  - 3
KW  - Karaciğer hasarı
KW  - karbon tetraklorür
KW  - meryemana dikeni
KW  - rat
KW  - zerdeçal.
N2  - This study aims to evaluate the protective efficacy of Curcuma longa and Silybum marianum on lipid peroxidation and some serum biochemical parameters in liver damage induced with carbon tetrachloride (CCl4) in rats. In the study, 60 4 month old Wistar albino rats weighing 250gr on average were used. Application of the treatment in the control groups were performed with three groups. The group I was administered corn oil twice for one week, group V was administered 100 mg/kg silymarin and group VI was administrated 80 mg/kg turmeric for 12 weeks by oral gavage. In the experimental group, 0,5 ml/kg CCl4 was injected intraperitoneally twice a week (Group II). The application of the treatment was performed in two groups for 12 weeks in the treatment groups. While the 100 mg/kg silymarin was given in the CCl4+silymarin group by gavage (Group III), the 80 mg/kg turmeric was given in the CCl4+turmeric group following of the injection of 0,5 ml/kg CCl4 (Group IV). At the end of the study, all liver tissues were examined with both histopathological and serum biochemical parameters. While the normal tissue structure was observed in the control group in the histopathological examination of the experimental and control groups, it was shown that there were fatty degeneration in the hepatocytes, deterioration in the structure of remark cords, hepatocyte degeneration, mononuclear cell infiltration areas composed of majority lymphocytes in the portal area and parenchyma, especially at portal area increasing connective tissue spread to parenchyma due to formation of lobulation. The liver lesions were found in the CCl4+silymarin and CCl4+turmeric groups as in Group II. While serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), low density lipoprotein (LDL) levels, liver malondialdehyde (MDA) and nitric oxide (NO) were increased in the CCl4-treated groups; the levels of high-density lipoprotein (HDL) and albumin values were decreased compared to the control group. When compared with the CCl4-treated group, it was observed that there was no statistically significant difference in the serum levels of CCl4+silymarin and CCl4+turmeric groups. It was observed that the serum biochemistry parameters were not significant change in the silymarin and turmeric groups compared with control group. In this study it has been concluded that there is a need for future studies in which different doses of silymarin and turmeric are used to reverse the liver damage and determine their efficacy.
CR  - 1. Dündar Y. Fitokimyasallar ve sağlıklı yaşam. Kocatepe Tıp Dergisi 2001; 2:131-138.
CR  - 2. Burroughs AK, Westaby D. Liver, biliary tract and
pancreatic disease. In: Kumar P, Clark M (eds),
Clinical Medicine. 6 th ed. Elsevier Saunders, 2005;
pp 347-417.
CR  - 3. Moeller RB. Hepatobiliary system. In: Plumlee KH.
(ed), Clinical Veterinary Toxicology. United States
2004: pp 61-62.
CR  - 4. Sherlock S. Chronic hepatitis and cirrhosis. Hepatology 1984; 4:5-28.
CR  - 5. Natarajan SK, Thomas S, Ramamoorthy P, et al.
Oxidative stress in the development of two different experimental models. J Gastroen Hepatol 2006;
21:947-957.
CR  - 6. McCord JM. The evolution of free radicals and oxidative stress. Am J Meb 2000; 108:652.
7. Betteridge DJ. What is oxidative stress? Metabolism
2000; 49:3-8.
CR  - 8. Aruoma OI. Nutrition and health aspects of free
radicals and antioxidants. Food Chem, 1994;
32:671-683.
CR  - 9. Halliwell B. How to characterize a biological antioxidant. Free Radical Res Commun 1990; 9:1-32.
CR  - 10. Southorn PA, Powis G. Free radicals in medicine.
Chemical 1988; 29:1516-1523.
CR  - 11. Sies H. Oxidative stress: Oxidants and antioxidants.
Exp Physiol 1997; 82:291-295.
CR  - 12. Palmieri B, Sblendorio V. Oxidative stress detection: What for? Eur Rev Med Pharmacol Sci 2006;
10:291-317.
CR  - 13. Moure A, Cruz JM, Franco D, et al. Natural
antioxidants from residual sources. Food
Chemistry 2001; 72:145-171.
CR  - 14. Naczk M, Shahidi F. Extraction and analysis of
phenolics in food. Journal of Chromatography
2004; 1054:95-111.
CR  - 15. Muriel P, Espinoza YR. Beneficial drugs for liver
disease: A review. J Appl Toxicol 2008; 28:93-103.
CR  - 16. Anthony KP, Saleh MA. Free radical scavenging and
antioxidant activities of silymarin components.
Antioxidants 2013; 2:398-407.
CR  - 17. Muriel P, Mourelle M. Prevention by silymarin of
membrane alterations in acute carbon tetrachloride liver damage. J Appl Toxicol 1990; 10:275-279.
CR  - 18. Wang DH, Ishii K, Zhen LX, Taketa K. Enhanced
liver injury in acatalasemic mice following exposure to carbon tetrachloride. Arch Toxicol 1996;
70:189-194.
CR  - 19. Eminzade S, Uras F, Izzettin FV. Silymarin protects
liver against toxic effects of anti-tuberculosis drugs
in experimental animals. Nutr Metab 2008; 5:18.
CR  - 20. Das KC, Das CK. Curcumin (diferuloylmethane), a
singlet oxygen (1O2) quencher. Biochemical and
Biophysical Research Communications 2002;
295,62–66.
CR  - 21. Naik SR, Thakare VN, Paitl SR. Protective effect of
curcumin on experimentally induced inflammation,
hepatotoxicity and cardiotoxicity in rats: Evidence
of its antioxidant property. Exp Toxicol Pathol
2011; 63:419-431.
CR  - 22. Maheswari RK, Singh AK, Gaddipati J, Srimal RC.
Multiple biological activities of curcumin: A short
review. Life Sci 2006; 78:2081-2087.
CR  - 23. Ammon HP, Walh MA. Pharmacology of Curcuma
longa. Planta Med 1991; 57:1-7.
CR  - 24. Luper S. A review of plants used in the treatment
liver disease. Altern Med Rev 1998; 3:410-421.
CR  - 25. Sung-Hwa K, Ho JC, Nari Y, Oh ST, Shin E, Shim KS,
Lee SM. Protective effect of a mixture of Aloe vera
and Silybum marianum against carbon tetrachloride induced acute hepatotoxicity and liver fibrosis.
J Pharmacol Sci 2009; 109:119-127.
CR  - 26. Kamalakkannan N, Rukkumani R, Varma PS,
Viswanathan P, Rajasekharan KN, Menon VP: Comparative effects of curcumin and an analogue of
curcumin in carbon tetrachloride induced hepatotoxicity in rats. Basic Clin Pharmacol 2005; 97:15-
21.
CR  - 27. Lowry OH, Rosebrough NJ, Farr AL Randall RJ. Protein measurement with the folin phenol reagent. J
Biol Chem 1951; 193:265-75.
CR  - 28. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V. A
novel method for measuring antioxidant capacity
and its application to monitoring the antioxidant
status in premature neonates. Clin Sci 1993;
84:407.
CR  - 29. Yoshioka T, Kawada K, Shimada T. Lipid
peroxidation in material and cord blood and
protective mechanism against activatedoxygen
toxicity in the blood. Am J Obstet Gynecol 1979;
135:372-376.
CR  - 30. Tracey WR, Tse J, Carter G. Lipopolysaccharideinduced changes in plasma nitrite and nitrate
concentrations in rats and mice: Pharmacological
evaluation of nitric oxide synthase inhibitors. J
Pharmacol Exp Ther 1995; 272:1011-1015.
CR  - 31. Shimiziu I. Antifibrogenic therapies in chronic HCV
infection. Curr Drug Targets Infect Disord 2001;
1:227-240.
CR  - 32. Hagerman AE, Riedl KM, Jones GA, Sovik KN,
Ritchard NT, Hartzfeld PW, Riechel TL. High molecular weight plant polyphenolics (tannins) as
biological antioxidants. J Agric Food Chem 1998;
46:1887-1892.
CR  - 33. Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin
protects the rat liver from CCl4 caused injury and
fibrogenesis by attenuating oxidative stres and
suppressing inflammation. Mol Pharmacol 2008;
73:399-409.
CR  - 34. Kevin PA, Mahmoud AS. Free radical scavenging
and antioxidant activities of silymarin components.
Antioxidants 2013; 2:398-407.
CR  - 35. Tamayo RP. Is cirrhosis of the liver experimentally
produced by CCl4 and adequate model of human
cirrhosis? Hepatology 1983; 3:112-120.
CR  - 36. Recknagel RO, Glende EA, Dolak JA, Waller RL.
Mechanism of carbon tetrachloride toxicity. Pharmacol Ther 1989; 43:139-154.
CR  - 37. Sarhan NAZ, El-Denshary ES, Hassan NS, AbuSalem FM, Abdel-Wahhab MA. Isoflavones enriched
soy protein prevents CCl4-induced hepatotoxicity
in rats. ISRN Pharmacol 2012; 8.
CR  - 38. Eidi A, Mortazavi P, Behzadi K, Rohani AH, Safi S.
Hepatoprotective effect of manganese chloride
against CCl4-induced liver injury in rats. Biol Trace
Elem Res 2013; 155:267-275.
CR  - 39. Lee TY, Wang GJ, Chiu JH, Lin HC. Long-term administration of Salvia miltiorrhiza ameliorates carbon tetrachloride induced hepatic fibrosis in rats. J
Pharm Pharmacol 2003; 55:1561-1568.
CR  - 40. Kus I, Ogeturk M, Oner H, Sahin S, Yekeler H, Sarsilmaz M. Protective effects of melatonin against carbontetrachloride induced hepatotoxicity in rats: A
light microscopic and biochemical study. Cell Biochem Funct 2005; 23:169-174.
CR  - 41. Chamulitrat W, Jordan SJ, Mason RP. Nitric oxide
production during endotoxic shock in carbon tetrachloride treated rats. Mol Pharm 1994; 46:391-
397.
CR  - 42. Srinivasan M, Rukkumani A. Sudheer R, Menon VP.
Ferulic acid, a natural protector against carbon
tetrachloride induced toxicity. Fundam Clin Pharmacol 2005; 19:491-496.
CR  - 43. Yılmaz S, Bahçecioğlu İH. Karbon tetraklorür ile
siroz oluşturulmuş ratlarda lipid peroksidasyonu,
antioksidan enzim ve pirüvat kinaz aktiviteleri.
Turk J Vet Anim Sci 2000; 24:25-28.
CR  - 44. Wu SJ, Lin YH, Chu CC, Tsai YH, Chao JCJ. Curcuminor saikosaponin a improves hepatic antioxidant
capacity and protects against CCl4-induced liver
injury in rats. J Med Food 2008; 11:224-229.
CR  - 45. Rajesh MG, Latha MS. Preliminary evaluation of the
antihepatotoxic activity of Kamilari, a polyherbal
formulation. J Ethanopharmacol 2004; 91:99-104.
CR  - 46. Muriel P, Moreno MG, Hernandez MC, Chávez E,
Alcantar LK. Resolution of liver fibrosis in CCl4 administration in the rat after discontinuation of
treatment: Effect of silymarin, silibinin, colchicine
and trimethyl colchicinic acid. Basic Clin Pharmacol
Toxicol 2005; 96:375-380.
CR  - 47. Tsai JH, Liu JY, Wu TT, et al. Effects of silymarin on
the resolution of liver fibrosis induced by carbon
tetrachloride in rats. J Viral Hepatitis 2008; 15:508-
-514.
CR  - 48. Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective
effect of curcumin in rat liver injury induced by
carbon tetrachloride. J Pharm Pharmacol 2000;
52:437-440.
UR  - https://dergipark.org.tr/tr/pub/eujhs/article/553096
L1  - https://dergipark.org.tr/tr/download/article-file/693935
ER  -